Arora Nalini, Kashyap Pallavi, Saren Dipankar, Meel Priyanka, Ghosh Joya, Yadav Ashish
Department of Obstetrics and Gynaecology, ESI-PGIMSR & ESIC Medical College, Kolkata, Joka, West Bengal India.
Department of Biochemistry, ESI-PGIMSR & ESIC Medical College, Kolkata, Joka, West Bengal India.
J Obstet Gynaecol India. 2025 Jun;75(3):246-252. doi: 10.1007/s13224-025-02117-5. Epub 2025 May 13.
The precise interpretation of thyroid function tests during pregnancy needs population-based trimester-specific data among pregnant women. This study was to determine trimester-specific reference range for free triiodothyronine (FT3), free thyroxine (FT4) and thyrotropin (TSH) among pregnant women in India.
In this prospective observational study, asymptomatic pregnant women with single fetus were enrolled from each trimester. Serum FT3, FT4, TSH and anti-thyroperoxidase (anti-TPO) antibodies were estimated using electrochemiluminescence technique.
Among 918 pregnant women, 82 women were excluded due to the presence of anti-TPO antibodies (76) and overt hypothyroidism (6). Among the remaining 836 women, 279 (33.3%) were in first trimester, 309 (36.9%) in second and 248 (29.6%) in third trimester. The 5th and 95th percentile values for each trimester were used as reference ranges. For all three hormones, the reference ranges for the first, second and third trimesters were: FT3 (1.59-3.64, 1.60-3.50 and 1.44-3.28 pg/dl), FT4 (0.64-1.12, 0.64-1.05 and 0.60-1.01 ng/dl) and TSH (0.21-4.95, 0.23-4.90 and 0.14-4.59 µIU/ml). The mean and median values for TSH between each trimester showed no statistically significant difference. No specific trend was seen for FT3 and TSH with advancing gestation. FT4 showed a decreasing trend with advancing trimester (P value: first versus second = 0.01, first versus third = 0.00003 and second versus third = 0.004). The reference range ( = 836) irrespective of trimester for thyroid hormones was: FT3 (1.53-3.46 pg/dl), FT4 (0.63-1.08 ng/dl) and TSH (0.19-4.72 µIU/ml).
The trimester-specific reference levels of TSH among pregnant women from India are significantly higher than 4 mIU/L (American Thyroid Association 2017).
孕期甲状腺功能检查的准确解读需要基于特定孕期的孕妇群体数据。本研究旨在确定印度孕妇游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)和促甲状腺激素(TSH)的特定孕期参考范围。
在这项前瞻性观察研究中,从每个孕期招募了单胎无症状孕妇。采用电化学发光技术测定血清FT3、FT4、TSH和抗甲状腺过氧化物酶(抗-TPO)抗体。
在918名孕妇中,82名因存在抗-TPO抗体(76名)和显性甲状腺功能减退(6名)而被排除。在其余836名妇女中,279名(33.3%)处于孕早期,309名(36.9%)处于孕中期,248名(29.6%)处于孕晚期。每个孕期的第5和第95百分位数用作参考范围。对于所有三种激素,孕早期、孕中期和孕晚期的参考范围分别为:FT3(1.59 - 3.64、1.60 - 3.50和1.44 - 3.28 pg/dl),FT4(0.64 - 1.12、0.64 - 1.05和0.60 - 1.01 ng/dl)和TSH(0.21 - 4.95、0.23 - 4.90和0.14 - 4.59 μIU/ml)。各孕期之间TSH的平均值和中位数无统计学显著差异。随着孕周增加,FT3和TSH未呈现特定趋势。FT4随孕周增加呈下降趋势(P值:孕早期与孕中期 = 0.01,孕早期与孕晚期 = 0.00003,孕中期与孕晚期 = 0.004)。不考虑孕期的甲状腺激素参考范围(n = 836)为:FT3(1.53 - 3.46 pg/dl),FT4(0.63 - 1.08 ng/dl)和TSH(0.19 - 4.72 μIU/ml)。
印度孕妇TSH的特定孕期参考水平显著高于4 mIU/L(美国甲状腺协会,2017年)。